Harnessing biomaterial architecture to drive anticancer innate immunity
Journal of Materials Chemistry B · 2023
DOI: 10.1039/d3tb01677c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Materials Chemistry B, 2023. Verfasst von Meredith A Davis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Boston University, Boston, Massachusetts, 02215, USA. mtep@bu.edu. Hauptthemen laut MEDLINE: Biocompatible Materials, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 291 Literaturangaben. Gefördert von: NIBIB NIH HHS, National Institutes of Health, Boston University.
Abstract (Originalsprache)
Structure-driven immunomodulatory biomaterial design enhances innate immune activation against the tumor microenvironment to drive anticancer immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Boston University, Boston, Massachusetts, 02215, USA. mtep@bu.edu.
- Department of Materials Science and Engineering, Boston University, Boston, Massachusetts, 02215, USA.
ORCID-Profile: Meredith A Davis, Ezra Cho, Michelle H Teplensky
Förderung
- NIBIB NIH HHS
- National Institutes of Health
- Boston University
Zitieren
APA
Davis, M. A., Cho, E., & Teplensky, M. H. (2023). Harnessing biomaterial architecture to drive anticancer innate immunity. Journal of Materials Chemistry B. https://doi.org/10.1039/d3tb01677c
Vancouver
Davis MA, Cho E, Teplensky MH. Harnessing biomaterial architecture to drive anticancer innate immunity. Journal of Materials Chemistry B. 2023. doi:10.1039/d3tb01677c
BibTeX
@article{Davis2023,
author = {Davis, Meredith A and Cho, Ezra and Teplensky, Michelle H},
title = {Harnessing biomaterial architecture to drive anticancer innate immunity},
journal = {Journal of Materials Chemistry B},
year = {2023},
doi = {10.1039/d3tb01677c}
}
EUVIMED